In an interview with CURE®, Emily Whitehead details her journey as a pediatric cancer survivor and how you won’t be able to predict it.
Emily Whitehead was just five years old when she was diagnosed with standard-risk pre-b acute lymphoblastic leukemia (ALL) in 2010. Though her parents, Tom and Kari, were told that she had a good chance of recovery, Emily underwent 16 months of chemotherapy. Then, just two weeks before a scheduled bone marrow transplant, Emily relapsed for a second time.
The Whiteheads thought they were out of options, until a phase 1 trial examining the use of CAR-T cell therapy opened up at Children’s Hospital of Philadelphia (CHOP) in April 2012, making Emily the first child to receive CAR-T cell therapy. This treatment turned out to be what the Whiteheads now call a miracle, and here, Emily, who has been in remission since May 2012, offers her take on what it was like to go through treatment and offers some advice to other patients who may be in a similar situation.
Transcription:
Emily: It's definitely a really difficult thing to go through, and you really need the support of other people, whether that be friends or family, or even a pet like my dog, Lucy. But I'm just so glad that more people have access to the treatment now, to less toxic treatments. And really all that you can do is just never stop and always keep fighting and just try to keep hoping you'll get through it.
I always tell them to never give up, to always keep fighting and to always believe in yourself and just to try and smile every day because you never know when things could change in an instant.
Shannen Doherty Gives a Cancer Update, ‘Kool & the Gang’ Member Dies From Cancer and More
December 1st 2023As Shannen Doherty revealed her cancer diagnoses and upcoming podcast and a woman with breast cancer completed her bucket list, here is what’s happening in the oncology space this week.
Read More
Author, Cancer Survivor Channeled Her Grief Into a Series of Books
November 2nd 2023Charlene Wexler, the Chicago-based author of the Laughter and Tears series of novels, is an ovarian cancer survivor who now has skin cancer. She told CURE® about how her son’s death from leukemia led to her re-invention as a writer.
Listen
FDA Expands Rozlytrek Indication to Include Some Solid Tumors in Children at Least 1 Month Old
October 21st 2023This expanded indication broadens the use of Rozlytrek for solid tumors to include children one month old, with the original approval in 2019 only including children one year and older.
Read More
Teaching Children — and the World — to Use Breathing Techniques for Cancer-Related Pain
February 2nd 2023In this episode of the “Cancer Horizons” podcast, “Rabbi G” discusses his global travels to teach breathwork to children with cancer, and gives an exercise listeners can use to decrease their pain and anxiety.
Listen